-
美国食品药品管理局解除对急性髓性白血病 CAR-T 疗法的临床搁置，Hemogenyx 获得缓刑
- 来源: https://www.pharmaceutical-technology.com/news/hemogenyx-gets-reprieve-as-fda-lifts-clinical-hold-on-aml-car-t-therapy/?cf-view
- 267
- 2024-02-15
-
具有下一代涂层的电化学传感器在POC的精密诊断方面取得进展
- 来源: https://www.labmedica.com/clinical-chemistry/articles/294800220/electrochemical-sensors-with-next-generation-coating-advances-precision-diagnostics-at-poc.html
- 191
- 2024-02-14
-
为精神分裂症开发的突破性血液测试预测最有效的治疗方法
- 来源: https://www.labmedica.com/molecular-diagnostics/articles/294800222/breakthrough-blood-test-developed-for-schizophrenia-predicts-most-effective-treatments.html
- 155
- 2024-02-14
-
美国食品药品管理局授予强生公司的尼泊卡利单抗用于 HDFN 的突破性治疗资格
- 来源: https://www.pharmaceutical-technology.com/news/fda-breakthrough-jj-nipocalimab/?cf-view
- 234
- 2024-02-14
-
英国创新署为乳腺癌治疗项目拨款
- 来源: https://www.pharmaceutical-technology.com/news/innovate-uk-funds-breast-cancer/?cf-view
- 187
- 2024-02-14
-
国际联盟确定糖尿病心血管疾病的生物标志物
- 来源: https://times.com/news/international-consortium-identifies-biomarkers-for-cardiovascular-disease-in-diabetes/
- 239
- 2024-02-14
-
NHS 推出 Pharmacy First 治疗七种常见病症
- 来源: https://healthmedia.blog.gov.uk/2024/02/01/pharmacy-first-what-you-need-to-know/
- 163
- 2024-02-14
-
Everly Health与国家肾脏基金会合作，扩大肾脏健康测试套件
- 来源: https://medcitynews.com/2024/02/kidney-disease-home-testing/
- 176
- 2024-02-13
-
HHS的新网络安全指南是未来新方向的原因
- 来源: https://medcitynews.com/2024/02/google-cloud-hhs-cybersecurity/
- 180
- 2024-02-13
-
MHRA 同意辉瑞-生物技术公司的 Comirnaty 疫苗变更许可证
- 来源: https://www.pharmaceutical-technology.com/news/mhra-licence-pfizer-biontech-vaccine/?cf-view
- 245
- 2024-02-13
